Executive Moves | Healthcare | BioTuesdays by Kilmer Lucas IR

Executive Moves

Matinas names Keith Murphy and Edward Neugeboren to BOD

Matinas BioPharma (NYSE American:MTNB) has appointed biotech industry veterans Keith Murphy and Edward Neugeboren to its board of directors (BOD) as independent members, effective today. Also effective today, Matinas...

March 11, 2025

Executive Moves

Andrew Gengos joins Terns as CFO

Terns Pharmaceuticals (NASDAQ:TERN) has announced the appointment of Andrew Gengos as chief financial officer (CFO), effective immediately. Mr. Gengos brings 25 years of leadership experience in life sciences and...

February 25, 2025

Executive Moves

Industry vet John Calcagnini joins Mesirow as a managing director, healthcare sector

Mesirow Investment Banking has announced the appointment of John Calcagnini as a managing director in its investment banking group based in Los Angeles. Mr. Calgagnini will co-lead the company’s healthcare sector...

February 19, 2025

Executive Moves

Titan launches equity research division; names Boris Peaker senior healthcare analyst

Titan Partners Group, a division of American Capital Partners, has announced the launch of its equity research division with the appointment of Boris Peaker, Ph.D., CFA, as managing director and senior equity research...

February 11, 2025

Executive Moves

Therma Bright adds Steve Raysely to advisory board

Therma Bright (TSXV:THRM; OTCQB:TBRIF) has announced the appointment of Steve Raysely to its advisory board. Mr. Raysely brings senior executive expertise in healthcare technology sales, marketing, and operations to the...

February 4, 2025

Executive Moves

Tonix names Siobhan Fogarty as CTO

Tonix Pharmaceuticals (NASDAQ:TNXP) has announced the appointment of Siobhan Fogarty as chief technical officer (CTO), effective immediately. Previously serving as executive vice president of product development at...

February 4, 2025

Executive Moves

Samir Hussein joins Ladenburg Thalmann in TMT investment banking

Ladenburg Thalmann has announced the appointment of Samir Hussein as managing director, TMT investment banking, based in New York. Mr. Hussein brings more than two decades of investment banking experience advising...

January 28, 2025

Executive Moves

Biodexa names Dr. Gary A. Shangold as CMO

Biodexa Pharmaceuticals (NASDAQ:BDRX) has announced the appointment of Dr. Gary A. Shangold as chief medical officer (CMO), effective immediately. The company stated that Dr. Shangold brings extensive experience across...

January 22, 2025

Executive Moves

Terence Tan joins William Blair’s Biopharma Investment Banking Group

William Blair, a global investment firm, has announced the addition of Terence Tan as managing director in its healthcare investment banking team. In this role, Mr. Tan will focus on delivering comprehensive advisory...

January 14, 2025

Executive Moves

Piper Sandler adds John Kerins to healthcare investment banking team

Leading investment bank Piper Sandler has announced the appointment of John Kerins as a managing director on its healthcare investment banking team. In this role, he will serve pharma services clients from the firm’s...

January 14, 2025

Executive Moves

Dr. Elena Ratner joins Eterna’s BOD

Eterna Therapeutics (NASDAQ:ERNA) has announced the appointment of Elena Ratner, MD, MBA, to its board of directors. The company states that Dr. Ratner will spearhead the strategic direction of Eterna’s efforts to...

January 9, 2025

Executive Moves

Tonix appoints Gary Ainsworth as VP of market access

Tonix Pharmaceuticals (NASDAQ:TNXP) has announced the appointment of Gary Ainsworth as vice president of market access, effective immediately. Mr. Ainsworth brings extensive pharmaceutical and healthcare consultancy...

January 8, 2025

Executive Moves

Grown Rogue announces Andrew Marchington as CFO and corporate secretary

Grown Rogue (CSE:GRIN; OTC:GRUSF) has appointed Andrew Marchington as its chief financial officer (CFO) and corporate secretary, succeeding Ryan Kee effective January 1, 2025. Previously serving as senior vice president...

January 2, 2025

Executive Moves

Avalo names Jennifer Riley as CSO

Avalo Therapeutics (NASDAQ: AVTX) has announced the appointment of Jennifer Riley as chief strategy officer (CSO), a newly created role effective January 1, 2025. Ms. Riley will oversee corporate strategy, as well as...

January 2, 2025

Executive Moves

Karyopharm appoints Lori Macomber as EVP, CFO, and treasurer

Karyopharm Therapeutics (NASDAQ: KPTI) has announced the appointment of Lori Macomber as executive vice president (EVP), chief financial officer (CFO), and treasurer, effective January 3, 2025. Ms. Macomber, who will be...

January 2, 2025

Executive Moves

Veteran life science equity analyst Chad Messer joins Lake Street Capital Markets

Seasoned life science equity analyst, Chad Messer, Ph.D., has joined Lake Street Capital Markets as a managing director of equity research. Based in New York, Dr. Messer has over two decades of experience spanning...

January 2, 2025

Executive Moves

Applied names John H. Johnson as EC; Shoshana Shendelman steps down as CEO

Applied Therapeutics (NASDAQ:APLT) has announced leadership changes, naming John H. Johnson as executive chairman (EC) and Les Funtleyder, formally CFO, as interim CEO. Shoshana Shendelman, MD, has stepped down from her...

December 20, 2024

Executive Moves

Adicet appoints Julie Maltzman as CMO

Adicet Bio (NASDAQ:ACET) has appointed Julie Maltzman, MD, as chief medical officer (CMO), effective January 13, 2025. Adicet reports that Dr. Maltzman succeeds Dr. Francesco Galimi, who has completed his tenure with...

December 18, 2024

Executive Moves

Jeb Ledell joins KalVista as COO

KalVista Pharmaceuticals (NASDAQ:KALV) has announced that Jeb Ledell has been appointed as chief operating officer (COO). Mr. Ledell brings more than 20 years of leadership and operational excellence in the...

December 16, 2024

Executive Moves

Rockwell names Jesse Neri as CFO

Rockwell Medical (NASDAQ:RMTI) announced the promotion of Jesse Neri to chief financial officer (CFO). Mr. Neri, formally Rockwell’s senior vice president of finance, joined the company in 2023, bringing more than 25...

December 12, 2024

Executive Moves

Outlook’s CEO steps down; Lawrence Kenyon named interim CEO

Outlook Therapeutics (NASDAQ:OTLK) has appointed Lawrence Kenyon, EVP, CFO, and board member, as interim CEO, effective immediately. Russell Trenary has stepped down as the company’s president and CEO. Mr. Kenyon has...

December 4, 2024

Executive Moves

MOBILion launches proteomics advisory board

Closely-held MOBILion Systems announced the formation of a proteomics advisory board to provide strategic guidance as the company advances the development of its next-generation high-resolution mass spectrometry...

November 20, 2024

Subscribe